Copyright © 1986 by the European Society of Cardiology.
© 1986 The European Society of Cardiology
Serum potassium concentrations are inversely related to ventricular, but not to atrial, arrhythmias in acute myocardial infarction
Cardiology Section, Department of Medicine, Diakonissehjemmet Hospital Haraldsplass, Bergen, Norway
Received 2 July 1985; revised 10 October 1985; .
Address for correspondence: J. E. Nordrehaug, MD, Department of Clinical Physiology, 5016 Haukeland Hospital, University of Bergen, Norway
Abstract
In a study of 1033 consecutive patients with acute myocardial infarction, serum potassium concentrations were determined on admission to hospital and studied with respect to the subsequent occurrence of atrial fibrillation and flutter and of ventricular tachycardia and fibrillation. The study cohort fulfilled the inclusion criteria for the Norwegian timolol trial in which they later took part. In multivariate analysis, with serum potassium concentrations as a continuous variable, age, the presence of ventricular tachycardia and fibrillation, and maximum level of aspartate aminotransferase greater than four times the upper limit of normal were significantly associated with the occurrence of atrial fibrillation and flutter, while serum potassium concentration was not. Serum potassium concentrations and time from onset of the infarction to hospital admission were significantly negatively associated with the occurrence of ventricular tachycardia and fibrillation; while age, cardiomegaly, transient hypotension, pathological Q-waves in the electrocardiogram, atrial fibrillation and flutter, and ventricular premature beats were positively related to these arrhythmias.
Key Words: Potassium arrhythmias acute myocardial infarction
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Ahmed, F. Zannad, T. E. Love, J. Tallaj, M. Gheorghiade, O. J. Ekundayo, and B. Pitt A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure Eur. Heart J., June 1, 2007; 28(11): 1334 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Gheeraert, M. L. De Buyzere, Y. M. Taeymans, T. C. Gillebert, J. P.S. Henriques, G. De Backer, and D. De Bacquer Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis Eur. Heart J., November 1, 2006; 27(21): 2499 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Auer, T. Weber, R. Berent, G. Lamm, and B. Eber Serum potassium level and risk of postoperative atrial fibrillation in patients undergoing cardiac surgery J. Am. Coll. Cardiol., August 18, 2004; 44(4): 938 - 939. [Full Text] [PDF] |
||||
![]() |
J. E. Macdonald and A. D. Struthers What is the optimal serum potassium level in cardiovascular patients? J. Am. Coll. Cardiol., January 21, 2004; 43(2): 155 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Curtis Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation Cardiovasc Res, July 1, 1998; 39(1): 194 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hansen, B. W. Johansson, and P. Nilsson-Ehle Metabolic, Electrocardiographic, and Hemodynamic Responses to Increased Circulating Adrenaline: Effects of Selective and Nonselective Beta Adrenoceptor Blockade Angiology, March 1, 1990; 41(3): 175 - 188. [PDF] |
||||



